RIGL20261218C41
RIGL Dec 18 2026 41.00 Call (RIGL261218C00041000)
option OPRA

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.